Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xiao-Xuan Xing"'
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objective: The CAMEL clinical trial (412 patients were randomly assigned to either camrelizumab plus chemotherapy (n = 205) or chemotherapy alone (n = 207)) demonstrated that camrelizumab plus chemotherapy (CC) improved the overall survival time (OS)
Externí odkaz:
https://doaj.org/article/548f6f1020b5446d871972e60444e06e
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Faced with limited and inadequate treatment options for patients with advanced gastric cancer or gastroesophageal junction cancer (GC/GEJC), researchers have turned toward, with the support of promising clinical trials, anti-PD-1/anti-PD-L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad12077506018b1808cdf2478c8b37e5
https://doi.org/10.4251/wjgo.v12.i11.1346
https://doi.org/10.4251/wjgo.v12.i11.1346
Publikováno v:
BMC Gastroenterology
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
BackgroundPerioperative patients are at risk of developing stress ulcers (SU), which can cause clinically important bleeding. Stress ulcer prophylaxis (SUP) is widely applied to the patients in Intensive care unit (ICU) as well as the general ward, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3bc459272e0eb1b4bdb593009d9214
https://pubmed.ncbi.nlm.nih.gov/34696716
https://pubmed.ncbi.nlm.nih.gov/34696716
Autor:
Ke Wang, Chen Zhu, Hua Yu Liang, Yan Qi Chu, Yu Qin Wang, Su Ying Yan, Xiao Xuan Xing, De Chun Jiang, Li Bo Zhao
Publikováno v:
The Annals of pharmacotherapy. 53(10)
Background: Adverse drug outcomes in the elderly have led to the development of lists of potentially inappropriate medications (PIMs), such as the Beers criteria, and these PIMs have been studied widely; however, it is still unclear whether PIM use i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d610790ba597a153bf3f0791a4a4151e
https://pubmed.ncbi.nlm.nih.gov/31129978
https://pubmed.ncbi.nlm.nih.gov/31129978
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Perioperative patients are at risk of developing stress ulcers (SU), which can cause clinically important bleeding. Stress ulcer prophylaxis (SUP) is widely applied to the patients in Intensive care unit (ICU) as well as the gener
Externí odkaz:
https://doaj.org/article/8591469df27b4c318af9793b1be9c7bb